Top list · Worldwide
943 pharma startups worldwide have raised money in rounds we track. These are the 50 that have raised the most, $24B between them, with the United States the most common home.
Altos Labs focuses on cellular rejuvenation programming to restore cell health and resilience, to reverse disease to transform medicine.
Founded 2021San Francisco, United States$3.0Blast round Sept 2021Retro Biosciences is a biotechnology company based in Redwood City, California, founded in May 2021.
Founded 2021Redwood City, United States$1.2Blast round May 2026Resilience is a cyber risk company based in San Francisco, founded in 2016 by experts from military intelligence, insurance, and technology.
Founded 2016New York, United States$860Mlast round Oct 2025Mineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension.
Founded 2019Radnor, United States$788Mlast round Jun 2026Dianthus Therapeutics is a biotech company developing new treatments for serious autoimmune diseases using a more targeted approach.
Founded 2019Waltham, United States$719Mlast round Mar 2026ADC Therapeutics develops antibody drug conjugates and non-antibody drug conjugate products.
Founded 2011Lausanne, Switzerland$646Mlast round Oct 2026Vaxcyte focuses on developing vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide.
Founded 2013San Carlos, United States$633Mlast round Jan 2026Axsome Therapeutics is a biopharmaceutical company that develops therapies for the management and treatment of neurological disorders.
Founded 2012New York, United States$577Mlast round May 2025CRISPR Therapeutics is focused on the development of transformative medicines using its proprietary CRISPR/Cas9 gene-editing platform.
Founded 2014United States$550Mlast round Mar 2026Immunovant is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases.
Founded 2018New York, United States$550Mlast round Dec 2025Korsana Biosciences develops THETA-enabled antibody therapies for neurodegenerative diseases including Alzheimer’s.
Founded -Waltham, United States$530Mlast round Sept 2026CellCentric is a clinical-stage biopharmaceutical company based in Cambridge, UK.
Founded 2004Saffron Walden, United Kingdom$525Mlast round May 2026MapLight Therapeutics is a biopharma company that offers a platform designed to discover and develop therapeutics for brain disorders.
Founded 2018Palo Alto, United States$523Mlast round Aug 2026OMass Therapeutics is a biotechnology company located in Oxford, UK, focused on discovering and developing novel small molecule medicines for rare diseases and
Founded 2016Oxford, United Kingdom$442Mlast round Oct 2026Ollin Biosciences is a clinical-stage biopharmaceutical company based in Austin, Texas, founded in 2023.
Founded -Austin, United States$430Mlast round Jun 2026Remedi SeniorCare provides pharmacy services by offering automatic therapeutic interchange education and consulting and transition services.
Founded 1954Baltimore, United States$430Mlast round Aug 2013Arcus Biosciences is a biopharmaceutical company that discovers, develops, and commercializes novel therapies for the treatment of cancer.
Founded 2015Hayward, United States$427Mlast round Oct 2025Zenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients.
Founded 2023Waltham, United States$420Mlast round Mar 2026SpringWorks Therapeutics is a biopharmaceutical company that develops medicines for patients with severe rare diseases and cancer.
Founded 2017Stamford, United States$400Mlast round Dec 2023Parabilis Medicines is a Grupo Bugio is a biopharmaceutical firm that specializes in creating medicines.
Founded -Cambridge, United States$380Mlast round Jun 2026Autolus is a biopharmaceutical company focused on T-cell programming and manufacturing technology.
Founded -London, United Kingdom$350Mlast round Feb 2024Madrigal Pharmaceuticals is a biopharmaceutical company developing therapeutics for the treatment of cardiovascular-metabolic diseases.
Founded 2011Conshohocken, United States$350Mlast round Jul 202589bio is a biopharmaceutical company that develops clinical-stage therapies for liver and cardiometabolic diseases.
Founded 2018San Francisco, United States$348Mlast round Jan 2025NPM is all about bringing the best and most innovative chemistry to their product discovery projects and collaborations.
Founded 2015United Kingdom$346Mlast round Aug 2025NGM Biopharmaceuticals Inc.
Founded 2008South San Francisco, United States$333Mlast round Mar 2015Haihe Biopharma is a biopharmaceutical company that develops cancer anti-tumour drugs.
Founded 2011China$317Mlast round Jul 2020Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.
Founded 2014Burlingame, United States$310Mlast round Jan 2026Maze Therapeutics is an operator of a biotechnology firm used to focus on translating genetic insights into new medicines.
Founded 2018South San Francisco, United States$300Mlast round Apr 2026Beeline Medicines is a clinical-stage biotechnology company based in Boston, Massachusetts, focused on developing precision therapies for autoimmune and inflamm
Founded 2025Stamford, United States$300Mlast round Apr 2026ACELYRIN is a biopharma company that identifies, acquires, and accelerates the development and commercialization of life-changing therapies.
Founded 2020Los Angeles, United States$300Mlast round Sept 2022Allakos is a biotechnology company developing therapeutic antibodies targeting allergy, inflammatory and proliferative diseases.
Founded 2012Redwood City, United States$294Mlast round Sept 2022Arcellx is a clinical-stage biotechnology company focused on developing innovative immunotherapies for cancer and other incurable diseases.
Founded 2015Redwood City, United States$285Mlast round Nov 2023Cullinan Therapeutics is a developer of an externally sourced cancer therapeutics used to end a drug program quickly.
Founded -Cambridge, United States$280Mlast round Apr 2024Mabwell Biotech is a Chinese innovative biopharmaceutical company.
Founded 2017Shanghai$279Mlast round Apr 2020Evonetix is a provider of a desktop platform designed to synthesize DNA at unprecedented accuracy and scale.
Founded 2015Cambridge, United Kingdom$276Mlast round Jan 2025Emalex Biosciences is a biotech startup that develops new treatments for central nervous system disorders.
Founded 2018Chicago, United States$270Mlast round Nov 2022GH Research is a biopharmaceutical company developing novel therapies for the management of mental illness.
Founded 2018Dublin, Ireland$268Mlast round Apr 2026Capital Rx, now rebranded as Judi Health, is a prominent enterprise health technology company specializing in pharmacy benefits management (PBM).
Founded 2017New York, United States$264Mlast round Sept 2025Compass Therapeutics is a biopharmaceutical company that focuses on drugging the immune system to treat human diseases.
Founded 2014Boston, United States$257Mlast round Aug 2025Aurinia develops and commercializes therapies to treat targeted patient populations suffering from serious auto-immune diseases.
Founded -Victoria, Canada$255Mlast round Jun 2026Kardigan is a heart health company developing drugs designed to make cardiovascular disease curable, preventable, and no longer the leading cause of death.
Founded 2023Princeton, United States$254Mlast round Oct 2025Anthos Therapeutics is a biopharmaceutical company that specializes in the treatment of cardiovascular and metabolic diseases.
Founded 2018Cambridge$250Mlast round Feb 2019LB Pharmaceuticals specializes in developing a treatment for schizophrenia.
Founded 2015Menlo Park, United States$250Mlast round Jul 2026ORIC Pharmaceuticals is a biopharmaceutical company that develops treatments that target the causes of therapeutic resistance.
Founded 2014South San Francisco, United States$248Mlast round May 2025Harmony Biosciences is a pharmaceutical company that develops and commercializes novel therapies for rare neurological disorders.
Founded 2017Plymouth Meeting, United States$248Mlast round Oct 2024Arcutis Biotherapeutics is a clinical-stage biopharmaceutical company focused on developing medical dermatology for unmet needs.
Founded 2016Westlake Village, United States$245Mlast round Feb 2024Companies whose funding rounds we classed as this sector, ranked by the total they have raised in rounds we hold. Nobody pays to be on a list.
Open any company for its rounds and investors, or search the investors who back pharma startups worldwide in the app, with filters, lists and exports.
GV
V
RPHealth startups worldwide12,811 companies · $81B
O
A
XAI startups worldwide10,238 companies · $830B
GV
V
RPBiotech startups worldwide7,127 companies · $70B
D
B
FTBig data startups worldwide3,812 companies · $220BAF
R
SFintech startups worldwide3,200 companies · $94B
O
A
BAI startups that raised in 20262,922 companies · $540B in 2026
FT
CE
PEnergy providers startups worldwide2,808 companies · $152B
P
OMarketing tech startups worldwide2,728 companies · $28B